Alcaro, S., C. Alteri, A. Artese, F. Ceccherini-Silberstein, G. Costa, F. Ortuso, F. Forbici, M.M. Santoro, L. Parrotta, P. Flandre, D. Descamps, V. Calvez, A.-G. Marcelin, C.F. Perno, T. Sing and V. Svicher: Docking Analysis and Resistance Evaluation of Clinically Relevant Mutations Associated with the HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors Nevirapine, Efavirenz and Etravirine. In: ChemMedChem 6, 12, 2203-2213 (2011).
doi: 10.1002/cmdc.201100362
url: http://dx.doi.org/10.1002/cmdc.201100362
localid: C125673F004B2D7B-814AE4C2010C44A6C12579C90050B2D5-Sing2011
Samri, A., G. Haas, J. Duntze, J.-M. Bouley, V. Calvez, C. Katlama and B. Autran: Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells. In: Journal of Virology 74, 19, 9306-9312 (2000).
doi: 10.1128/​JVI.74.19.9306-9312.2000
http://edoc.mpg.de
The Max Planck Society does not take any responsibility for the content of this export.